Respiratory Medicine
Volume 104, Issue 1 , Pages 67-75 , January 2010

Changes in management of chronic obstructive pulmonary disease (COPD) in primary care: EMMEPOC study

  • Néstor Soler

      Affiliations

    • Servei de Pneumologia, Institut del Tòrax, Hospital Clínic, IDIBAPS, Universitat de Barcelona, Villarroel 170, 08036 – Barcelona, Spain
    • CIBER de Enfermedades Respiratorias (CIBERES), Spain
    • Corresponding Author InformationCorresponding author. Servei de Pneumologia, Institut del Tòrax, Hospital Clínic, IDIBAPS, Universitat de Barcelona, Villarroel 170, 08036 – Barcelona, Spain. Tel.: +34932275549; fax: +34 204852789.
  • ,
  • Eugeni Ballester

      Affiliations

    • Servei de Pneumologia, Institut del Tòrax, Hospital Clínic, IDIBAPS, Universitat de Barcelona, Villarroel 170, 08036 – Barcelona, Spain
    • CIBER de Enfermedades Respiratorias (CIBERES), Spain
  • ,
  • Antonio Martín

      Affiliations

    • Medical Unit, Pfizer, Madrid, Spain
  • ,
  • Elena Gobartt

      Affiliations

    • Medical Department, Boehringer-Ingelheim, Barcelona, Spain
  • ,
  • Marc Miravitlles

      Affiliations

    • Servei de Pneumologia, Institut del Tòrax, Hospital Clínic, IDIBAPS, Universitat de Barcelona, Villarroel 170, 08036 – Barcelona, Spain
    • CIBER de Enfermedades Respiratorias (CIBERES), Spain
  • ,
  • Antoni Torres

      Affiliations

    • Servei de Pneumologia, Institut del Tòrax, Hospital Clínic, IDIBAPS, Universitat de Barcelona, Villarroel 170, 08036 – Barcelona, Spain
    • CIBER de Enfermedades Respiratorias (CIBERES), Spain

Received 26 May 2009 ,Accepted 6 August 2009.

References 

  1. Pouwels R, Buist S, Calverley P, Ch Jenkins, Hurd S on behalf of the GOLD Scientific Committee. Global strategy for the diagnosis, management and prevention of chronic obstructive pulmonary disease. NHLBI/WHO Global Initiative for Chronic Obstructive Lung Disease (GOLD) Workshop Summary. Am J Respir Crit Care Med. 2001;163:1256–1576
  2. Sobradillo V, Miravitlles M, Gabriel R, et al. Geographic variations in prevalence and underdiagnosis of COPD: results of IBERCOP multicentre epidemiological study. Chest. 2000;118:881–989
  3. Barberà JA, Peces-Barba G, Agustí AGN, et al. Guidelines for diagnosis and treatment of chronic obstructive pulmonary disease, Arch Bronconeumol. 2001;37:297–316
  4. Miravitlles M, De la Roza C, Morera J, et al. Chronic respiratory symptoms, spirometry and knowledge of COPD among general population. Respi Med. 2006;100:1973–1980
  5. De Miguel J, Izquierdo JL, Rodríguez-González JM, et al. Reliability of chronic obstructive disease diagnosis by primary care physicians and pneumologists in Spain. Predictive factors. Arch Bronconeumol. 2003;39:195–202
  6. Clotet J, Gómez-Arbonés X, Ciria C, et al. Spirometry is a good method for detecting and monitoring chronic obstructive pulmonary disease in high-risk smokers in primary health care. Arch Bronconeumol. 2004;40:155–159
  7. Bednarek M, Maciejewski J, Wozniak M, et al. Prevalence, severity, and under-diagnosis of COPD in primary care setting. Online First Thorax. January 30, 2008;10.1136/thx.2007.085456
  8. Walker PP, Mitchell P, Diamantea F, et al. Effect of primary-care spirometry o the diagnosis and management of COPD. Eur Respir J. 2006;28:945–952
  9. Zaas D, Wise R, Wiener C. Airway obstruction is common but unsuspected in patients admitted to a general medicine service. Chest. 2004;125:106–111
  10. Buffels J, Degryse J, Heyrman J, et al. Office spirometry significant improves early detection of COPD in general practice. The DIDASCO study. Chest. 2004;125:1394–1399
  11. Derom E, Veel V, Liistro G, et al. Primary care spirometry. Eur Respir J. 2008;31:197–2003
  12. Lusuardi M, De Benedetto F, Paggiaro P, et al. A randomized controlled trial on office spirometry in asthma and COPD in standard general practice: a comparative evaluation in Italian study. Chest. 2006;129:844–852
  13. Walters JA, Hansen EC, Haydn W, Wood-Baker R. Under-diagnosis of chronic pulmonary disease: a qualitative study in primary care. Respir Med. 2008;102(5):738–743
  14. Schermer TR, Jacobs JE, Chavannes NH, et al. Validity of spirometric testing in a general practice population of patients with chronic obstructive pulmonary disease (COPD). Thorax. 2003;58:861–866
  15. Walkers JA, Hansen EC, Johns DP, et al. A mixed methods study to compare models of spirometry delivery in primary care for patients at risk of Chronic Obstructive Pulmonary Disease (COPD). Online First Thorax. December 5, 2007;10.1136/thx.2007.082659
  16. Vandevoorde J, Verbanck S, Scchuermans D, et al. Obstructive and restrictive spirometric patterns: fixed cut-offs for FEV1/FEV6 and FEV6. Eur Respir J. 2006;378–383
  17. Akpinar-Elci M, Fedan K, Enright P. FEV6 as a surrogate for FVC in detecting airways obstruction and restriction in the workplace. Eur Respir J. 2006;27:374–377
  18. Lamprecht B, Schirnhofer L, Tiefenbacher F, et al. Six-second spirometry for detection airway obstruction. Am J Respir Crit Care Med. 2007;176:460–464
  19. Fergusson GT, Enright P, Buist S, Higgins M. Office spirometry for lung health assessment in adults. Chest. 2000;117:1146–1161
  20. Roca J, Burgos F, Sunyer J, et al. References values for forced spirometry. Eur Respir J. 1998;11:1354–1362
  21. Izquierdo JL, Rodriguez-González JM, de Lucas P, et al. Has the treatment of COPD changed in Spain? Results of a community study (VICE). Rev Clin Esp. 2008;1:18–25
  22. Smith CJ, Gribbin J, Challen KB, Hubbard RB. The impact of the 2004 NICE guideline and 2003 general medical services contract on COPD in primary care in UK. QJM. 2008;101:145–153
  23. Vandevoorde J, Verbanck S, Scchuermans D, et al. FEV1/FEV6 as alternative for FEV1/FVC and FVC in the spirometric detection for airway obstruction and restriction. Chest. 2005;127:1560–1564
  24. Swanney MP, Jensen RL, Crichton DA, et al. FEV6 is an acceptable surrogate for FVC in the spirometric diagnosis of airway obstruction and restriction. Am J Respir Crit Care Med. 2000;162:917–919
  25. Swanney MP, Beckert LE, Frampton CM, et al. Validity of the American Thoracic Society and other spirometric algorithms using FVC and forced expiratory volume at 6 s for predicting a reduced total lung capacity. Chest. 2004;26:1861–1866
  26. Miller MR, Hankinson J, Brusasco V, et al. ATS/ERS Task Force. Standardisation of spirometry. Eur Respir J. 2005;26:319–338
  27. Hansen JE, Sun XC, Wasserman K. Should forced expiratory volume in six seconds replace forced vital capacity to detect airway obstruction?. Eur Respir J. 2006;27:1244–1250
  28. Bolton CE, Ionescu A, Edwards P, et al. Attaining a correct diagnosis of COPD in general practice. Respir Med. 2005;99:493–500
  29. Lucas AE, Smeenk FW, Smeele IJ, van Schayck CP. Over-treatment with inhaled corticosteroids and diagnostic problems in primary care patients, an exploratory study. Advanced published Fam Pract. February 27, 2008;1–6
  30. Van der Boom G, Van Schayck CP, Van Möllén MP, et al. Active detection of chronic pulmonary disease and asthma in the general population: results and economic consequences of the DIMCA program. Am J Respir Crit Care Med. 1998;158:1730–1738
  31. Burge PS. EUROSCOP, ISOLDE and the Copenhagen city lung study. Thorax. 1999;54:287–288
  32. Donohue JF, Van Noord J, Bateman ED, et al. A 6-month, placebo-controlled study comparing lung function and health status changes in COPD patients treated with tiotropium or salmeterol. Chest. 2002;122:47–55
  33. Rudolf M. The reality of drug use in COPD. The European perspective. Chest. 2000;117:29S–32S
  34. Dales RE, Vandemheen K, Clinch J, et al. Spirometry in the primary care setting. Influence on clinical diagnosis and management of airflow obstruction. Chest. 2005;128:2443–2447
  35. Hilleman DE, Dewan N, Malesker M, et al. Pharmacoeconomic evaluation of COPD. Chest. 2000;118:1278–1285
  36. Wise RA, Tashkin DP. Optimizing treatment of obstructive pulmonary disease: an assessment of current therapies. Am J Med. 2007;120:S4–S13

PII: S0954-6111(09)00259-5

doi: 10.1016/j.rmed.2009.08.003

Respiratory Medicine
Volume 104, Issue 1 , Pages 67-75 , January 2010